ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Coagulation Factor IX Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-36J6919
Home | Market Reports | Health| Pharmacy
Global Coagulation Factor IX Market Insights Forecast to 2028
BUY CHAPTERS

Global Coagulation Factor IX Market Research Report 2025

Code: QYRE-Auto-36J6919
Report
August 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
CSL Behring
Grifols S A
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo

Coagulation Factor IX Market Size

The global market for Coagulation Factor IX was valued at US$ 395 million in the year 2024 and is projected to reach a revised size of US$ 582 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Coagulation Factor IX Market

Coagulation Factor IX Market

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coagulation Factor IX, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factor IX.
The Coagulation Factor IX market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coagulation Factor IX market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coagulation Factor IX manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Coagulation Factor IX Market Report

Report Metric Details
Report Name Coagulation Factor IX Market
Accounted market size in year US$ 395 million
Forecasted market size in 2031 US$ 582 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Coagulation Factor IX (Plasma Derived)
  • Coagulation Factor IX (Recombinant)
Segment by Application
  • Adult
  • Kids
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, CSL Behring, Grifols, Novo Nordisk, Bioverativ, Sanquin, Takeda, Baxter, Aptevo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Coagulation Factor IX in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Coagulation Factor IX Market growing?

Ans: The Coagulation Factor IX Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Coagulation Factor IX Market size in 2031?

Ans: The Coagulation Factor IX Market size in 2031 will be US$ 582 million.

Who are the main players in the Coagulation Factor IX Market report?

Ans: The main players in the Coagulation Factor IX Market are Pfizer, CSL Behring, Grifols, Novo Nordisk, Bioverativ, Sanquin, Takeda, Baxter, Aptevo

What are the Application segmentation covered in the Coagulation Factor IX Market report?

Ans: The Applications covered in the Coagulation Factor IX Market report are Adult, Kids

What are the Type segmentation covered in the Coagulation Factor IX Market report?

Ans: The Types covered in the Coagulation Factor IX Market report are Coagulation Factor IX (Plasma Derived), Coagulation Factor IX (Recombinant)

Recommended Reports

Coagulation Analyzers

Hemostasis & Materials

Coagulation Factors & Related

1 Coagulation Factor IX Market Overview
1.1 Product Definition
1.2 Coagulation Factor IX by Type
1.2.1 Global Coagulation Factor IX Market Value Comparison by Type (2024 VS 2031)
1.2.2 Coagulation Factor IX (Plasma Derived)
1.2.3 Coagulation Factor IX (Recombinant)
1.3 Coagulation Factor IX by Application
1.3.1 Global Coagulation Factor IX Market Value by Application (2024 VS 2031)
1.3.2 Adult
1.3.3 Kids
1.4 Global Coagulation Factor IX Market Size Estimates and Forecasts
1.4.1 Global Coagulation Factor IX Revenue 2020-2031
1.4.2 Global Coagulation Factor IX Sales 2020-2031
1.4.3 Global Coagulation Factor IX Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Coagulation Factor IX Market Competition by Manufacturers
2.1 Global Coagulation Factor IX Sales Market Share by Manufacturers (2020-2025)
2.2 Global Coagulation Factor IX Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Coagulation Factor IX Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Coagulation Factor IX, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coagulation Factor IX, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coagulation Factor IX, Product Type & Application
2.7 Global Key Manufacturers of Coagulation Factor IX, Date of Enter into This Industry
2.8 Global Coagulation Factor IX Market Competitive Situation and Trends
2.8.1 Global Coagulation Factor IX Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Coagulation Factor IX Players Market Share by Revenue
2.8.3 Global Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Coagulation Factor IX Market Scenario by Region
3.1 Global Coagulation Factor IX Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Coagulation Factor IX Sales by Region: 2020-2031
3.2.1 Global Coagulation Factor IX Sales by Region: 2020-2025
3.2.2 Global Coagulation Factor IX Sales by Region: 2026-2031
3.3 Global Coagulation Factor IX Revenue by Region: 2020-2031
3.3.1 Global Coagulation Factor IX Revenue by Region: 2020-2025
3.3.2 Global Coagulation Factor IX Revenue by Region: 2026-2031
3.4 North America Coagulation Factor IX Market Facts & Figures by Country
3.4.1 North America Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Coagulation Factor IX Sales by Country (2020-2031)
3.4.3 North America Coagulation Factor IX Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Coagulation Factor IX Market Facts & Figures by Country
3.5.1 Europe Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Coagulation Factor IX Sales by Country (2020-2031)
3.5.3 Europe Coagulation Factor IX Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coagulation Factor IX Market Facts & Figures by Region
3.6.1 Asia Pacific Coagulation Factor IX Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Coagulation Factor IX Sales by Region (2020-2031)
3.6.3 Asia Pacific Coagulation Factor IX Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Coagulation Factor IX Market Facts & Figures by Country
3.7.1 Latin America Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Coagulation Factor IX Sales by Country (2020-2031)
3.7.3 Latin America Coagulation Factor IX Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coagulation Factor IX Market Facts & Figures by Country
3.8.1 Middle East and Africa Coagulation Factor IX Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Coagulation Factor IX Sales by Country (2020-2031)
3.8.3 Middle East and Africa Coagulation Factor IX Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coagulation Factor IX Sales by Type (2020-2031)
4.1.1 Global Coagulation Factor IX Sales by Type (2020-2025)
4.1.2 Global Coagulation Factor IX Sales by Type (2026-2031)
4.1.3 Global Coagulation Factor IX Sales Market Share by Type (2020-2031)
4.2 Global Coagulation Factor IX Revenue by Type (2020-2031)
4.2.1 Global Coagulation Factor IX Revenue by Type (2020-2025)
4.2.2 Global Coagulation Factor IX Revenue by Type (2026-2031)
4.2.3 Global Coagulation Factor IX Revenue Market Share by Type (2020-2031)
4.3 Global Coagulation Factor IX Price by Type (2020-2031)
5 Segment by Application
5.1 Global Coagulation Factor IX Sales by Application (2020-2031)
5.1.1 Global Coagulation Factor IX Sales by Application (2020-2025)
5.1.2 Global Coagulation Factor IX Sales by Application (2026-2031)
5.1.3 Global Coagulation Factor IX Sales Market Share by Application (2020-2031)
5.2 Global Coagulation Factor IX Revenue by Application (2020-2031)
5.2.1 Global Coagulation Factor IX Revenue by Application (2020-2025)
5.2.2 Global Coagulation Factor IX Revenue by Application (2026-2031)
5.2.3 Global Coagulation Factor IX Revenue Market Share by Application (2020-2031)
5.3 Global Coagulation Factor IX Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Coagulation Factor IX Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Company Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Behring Coagulation Factor IX Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grifols Coagulation Factor IX Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Company Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novo Nordisk Coagulation Factor IX Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Bioverativ
6.5.1 Bioverativ Company Information
6.5.2 Bioverativ Description and Business Overview
6.5.3 Bioverativ Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bioverativ Coagulation Factor IX Product Portfolio
6.5.5 Bioverativ Recent Developments/Updates
6.6 Sanquin
6.6.1 Sanquin Company Information
6.6.2 Sanquin Description and Business Overview
6.6.3 Sanquin Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanquin Coagulation Factor IX Product Portfolio
6.6.5 Sanquin Recent Developments/Updates
6.7 Takeda
6.7.1 Takeda Company Information
6.7.2 Takeda Description and Business Overview
6.7.3 Takeda Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Takeda Coagulation Factor IX Product Portfolio
6.7.5 Takeda Recent Developments/Updates
6.8 Baxter
6.8.1 Baxter Company Information
6.8.2 Baxter Description and Business Overview
6.8.3 Baxter Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Baxter Coagulation Factor IX Product Portfolio
6.8.5 Baxter Recent Developments/Updates
6.9 Aptevo
6.9.1 Aptevo Company Information
6.9.2 Aptevo Description and Business Overview
6.9.3 Aptevo Coagulation Factor IX Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aptevo Coagulation Factor IX Product Portfolio
6.9.5 Aptevo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coagulation Factor IX Industry Chain Analysis
7.2 Coagulation Factor IX Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coagulation Factor IX Production Mode & Process Analysis
7.4 Coagulation Factor IX Sales and Marketing
7.4.1 Coagulation Factor IX Sales Channels
7.4.2 Coagulation Factor IX Distributors
7.5 Coagulation Factor IX Customer Analysis
8 Coagulation Factor IX Market Dynamics
8.1 Coagulation Factor IX Industry Trends
8.2 Coagulation Factor IX Market Drivers
8.3 Coagulation Factor IX Market Challenges
8.4 Coagulation Factor IX Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
CSL Behring
Grifols S A
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
List of Tables
 Table 1. Global Coagulation Factor IX Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Coagulation Factor IX Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Coagulation Factor IX Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Coagulation Factor IX Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Coagulation Factor IX Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Coagulation Factor IX Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Coagulation Factor IX Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Coagulation Factor IX Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Coagulation Factor IX, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Coagulation Factor IX, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Coagulation Factor IX, Product Type & Application
 Table 12. Global Key Manufacturers of Coagulation Factor IX, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Coagulation Factor IX by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor IX as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Coagulation Factor IX Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Coagulation Factor IX Sales by Region (2020-2025) & (K Units)
 Table 18. Global Coagulation Factor IX Sales Market Share by Region (2020-2025)
 Table 19. Global Coagulation Factor IX Sales by Region (2026-2031) & (K Units)
 Table 20. Global Coagulation Factor IX Sales Market Share by Region (2026-2031)
 Table 21. Global Coagulation Factor IX Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Coagulation Factor IX Revenue Market Share by Region (2020-2025)
 Table 23. Global Coagulation Factor IX Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Coagulation Factor IX Revenue Market Share by Region (2026-2031)
 Table 25. North America Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
 Table 27. North America Coagulation Factor IX Sales by Country (2026-2031) & (K Units)
 Table 28. North America Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Coagulation Factor IX Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Coagulation Factor IX Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Coagulation Factor IX Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Coagulation Factor IX Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Coagulation Factor IX Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Coagulation Factor IX Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Coagulation Factor IX Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Coagulation Factor IX Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Coagulation Factor IX Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Coagulation Factor IX Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Coagulation Factor IX Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Coagulation Factor IX Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Coagulation Factor IX Sales (K Units) by Type (2020-2025)
 Table 51. Global Coagulation Factor IX Sales (K Units) by Type (2026-2031)
 Table 52. Global Coagulation Factor IX Sales Market Share by Type (2020-2025)
 Table 53. Global Coagulation Factor IX Sales Market Share by Type (2026-2031)
 Table 54. Global Coagulation Factor IX Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Coagulation Factor IX Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Coagulation Factor IX Revenue Market Share by Type (2020-2025)
 Table 57. Global Coagulation Factor IX Revenue Market Share by Type (2026-2031)
 Table 58. Global Coagulation Factor IX Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Coagulation Factor IX Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Coagulation Factor IX Sales (K Units) by Application (2020-2025)
 Table 61. Global Coagulation Factor IX Sales (K Units) by Application (2026-2031)
 Table 62. Global Coagulation Factor IX Sales Market Share by Application (2020-2025)
 Table 63. Global Coagulation Factor IX Sales Market Share by Application (2026-2031)
 Table 64. Global Coagulation Factor IX Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Coagulation Factor IX Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Coagulation Factor IX Revenue Market Share by Application (2020-2025)
 Table 67. Global Coagulation Factor IX Revenue Market Share by Application (2026-2031)
 Table 68. Global Coagulation Factor IX Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Coagulation Factor IX Price (USD/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Coagulation Factor IX Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. CSL Behring Company Information
 Table 76. CSL Behring Description and Business Overview
 Table 77. CSL Behring Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Behring Coagulation Factor IX Product
 Table 79. CSL Behring Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Grifols Coagulation Factor IX Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. Novo Nordisk Company Information
 Table 86. Novo Nordisk Description and Business Overview
 Table 87. Novo Nordisk Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Novo Nordisk Coagulation Factor IX Product
 Table 89. Novo Nordisk Recent Developments/Updates
 Table 90. Bioverativ Company Information
 Table 91. Bioverativ Description and Business Overview
 Table 92. Bioverativ Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Bioverativ Coagulation Factor IX Product
 Table 94. Bioverativ Recent Developments/Updates
 Table 95. Sanquin Company Information
 Table 96. Sanquin Description and Business Overview
 Table 97. Sanquin Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Sanquin Coagulation Factor IX Product
 Table 99. Sanquin Recent Developments/Updates
 Table 100. Takeda Company Information
 Table 101. Takeda Description and Business Overview
 Table 102. Takeda Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Takeda Coagulation Factor IX Product
 Table 104. Takeda Recent Developments/Updates
 Table 105. Baxter Company Information
 Table 106. Baxter Description and Business Overview
 Table 107. Baxter Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Baxter Coagulation Factor IX Product
 Table 109. Baxter Recent Developments/Updates
 Table 110. Aptevo Company Information
 Table 111. Aptevo Description and Business Overview
 Table 112. Aptevo Coagulation Factor IX Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Aptevo Coagulation Factor IX Product
 Table 114. Aptevo Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Coagulation Factor IX Distributors List
 Table 118. Coagulation Factor IX Customers List
 Table 119. Coagulation Factor IX Market Trends
 Table 120. Coagulation Factor IX Market Drivers
 Table 121. Coagulation Factor IX Market Challenges
 Table 122. Coagulation Factor IX Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Coagulation Factor IX
 Figure 2. Global Coagulation Factor IX Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Coagulation Factor IX Market Share by Type: 2024 & 2031
 Figure 4. Coagulation Factor IX (Plasma Derived) Product Picture
 Figure 5. Coagulation Factor IX (Recombinant) Product Picture
 Figure 6. Global Coagulation Factor IX Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Coagulation Factor IX Market Share by Application: 2024 & 2031
 Figure 8. Adult
 Figure 9. Kids
 Figure 10. Global Coagulation Factor IX Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Coagulation Factor IX Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Coagulation Factor IX Sales (2020-2031) & (K Units)
 Figure 13. Global Coagulation Factor IX Average Price (USD/Unit) & (2020-2031)
 Figure 14. Coagulation Factor IX Report Years Considered
 Figure 15. Coagulation Factor IX Sales Share by Manufacturers in 2024
 Figure 16. Global Coagulation Factor IX Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Coagulation Factor IX Players: Market Share by Revenue in Coagulation Factor IX in 2024
 Figure 18. Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Coagulation Factor IX Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 21. North America Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 25. Europe Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Coagulation Factor IX Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Coagulation Factor IX Revenue Market Share by Region (2020-2031)
 Figure 33. China Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Coagulation Factor IX Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Coagulation Factor IX Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Coagulation Factor IX Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Coagulation Factor IX by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Coagulation Factor IX by Type (2020-2031)
 Figure 55. Global Coagulation Factor IX Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Coagulation Factor IX by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Coagulation Factor IX by Application (2020-2031)
 Figure 58. Global Coagulation Factor IX Price (USD/Unit) by Application (2020-2031)
 Figure 59. Coagulation Factor IX Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Factor IX Deficiency Treatment Market Research Report 2024
Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor IX Market Research Report 2025
Global Human Coagulation Factor IX Market Research Report 2024
Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Factor Xa Market Research Report 2025
Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor VII Market Insights Forecast to 2030
Global Factor IX Complex Market Research Report 2024
Human Prothrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Factor IX Complex Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prothrombin Complex Market Research Report 2024
Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Coagulation Factor VIII Market Research Report 2020
Global Clotting Factor Market Research Report 2025
Global Human Prothrombin Complex Market Research Report 2025
Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Humanes Antithrombin III Konzentrat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions